BonnieJeanne Gerety - Insider of Brain Scientific BonnieJeanne Gerety is Chief Officer of Brain Scientific. BonnieJeanne Gerety corporate profile, background and performance evaluation including other Brain Scientific executives -->

BonnieJeanne Gerety - Brain Scientific Chief Officer

BRSF Stock  USD 0.75  0.00  0.00%   

Insider

BonnieJeanne Gerety is Chief Officer of Brain Scientific
Age 61
Phone917-388-1578
Webhttps://www.brainscientific.com

Brain Scientific Management Efficiency

The company has return on total asset (ROA) of (1.1699) % which means that it has lost $1.1699 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (45.9733) %, meaning that it created substantial loss on money invested by shareholders. Brain Scientific's management efficiency ratios could be used to measure how well Brain Scientific manages its routine affairs as well as how well it operates its assets and liabilities.
Brain Scientific currently holds 9.97 M in liabilities with Debt to Equity (D/E) ratio of 0.18, which may suggest the company is not taking enough advantage from borrowing. Brain Scientific has a current ratio of 0.58, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist Brain Scientific until it has trouble settling it off, either with new capital or with free cash flow. So, Brain Scientific's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Brain Scientific sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Brain to invest in growth at high rates of return. When we think about Brain Scientific's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

INSIDER Age

Laszlo GaramszegiAurora Spine
52
Christopher LesovitzSTRATA Skin Sciences
41
Mark SaxtonNeuropace
59
Bart BracyAnika Therapeutics
N/A
Chi NguyenNeuropace
47
Niclas EmanuelssonCellink AB
52
Erica BellBICO Group AB
50
Karin DanielssonBICO Group AB
41
Ronen CPAIcecure Medical
56
David MeyerAurora Spine
N/A
Jason CliftonBICO Group AB
N/A
Michael FavetNeuropace
54
David ColleranAnika Therapeutics
52
Mikael EngblomCellink AB
46
Jason CliftonCellink AB
N/A
Chad ClouseAurora Spine
N/A
Erik GatenholmBICO Group AB
34
Trent NorthcuttAurora Spine
56
Hector MartinezCellink AB
38
HuiLan WuAinos Inc
63
Shay LevavIcecure Medical
47
Brain Scientific Inc., a medtech company, provides neurology-focused medical devices and electric motors in the United States. Brain Scientific Inc. was founded in 2013 and is headquartered in Sarasota, Florida. Brain Scientific operates under Medical Devices classification in the United States and is traded on OTC Exchange. It employs 28 people. Brain Scientific [BRSF] is a Pink Sheet which is traded between brokers over the counter.

Management Performance

Brain Scientific Leadership Team

Elected by the shareholders, the Brain Scientific's board of directors comprises two types of representatives: Brain Scientific inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Brain. The board's role is to monitor Brain Scientific's management team and ensure that shareholders' interests are well served. Brain Scientific's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Brain Scientific's outside directors are responsible for providing unbiased perspectives on the board's policies.
Hassan Kotob, CEO Chairman
Irina Nazarova, Director Marketing
Farid Anthony, Chief Officer
Daniel Cloutier, Chief Director
Kevin Winterfield, VP Communications
BonnieJeanne Gerety, Chief Officer
Vadim Sakharov, Consultant
Mark Broderick, Pres Corp
Stuart Bernstein, VP Marketing

Brain Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Brain Scientific a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Other Information on Investing in Brain Pink Sheet

Brain Scientific financial ratios help investors to determine whether Brain Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Brain with respect to the benefits of owning Brain Scientific security.

Discover investing ideas

Utilize additional investing modules